{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:01:28Z","timestamp":1791900088247,"version":"4.3.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109927","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T08:05:34Z","timestamp":1677485134000},"page":"109927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats"],"prefix":"10.1016","volume":"117","author":[{"given":"Adel A.","family":"Gomaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan S.M.","family":"Farghaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmy K.","family":"Hemida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.109927_b0005","unstructured":"WHO, 2021, World Health Organization, Dementia (2021) https:\/\/www .who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"10.1016\/j.intimp.2023.109927_b0010","unstructured":"Statistics D, 2021, Alzheimer\u2019s Disease International, dementia-statistic (2021), https:\/\/www.alzint.org\/about\/dementia-facts-figures\/ dementia-statistic."},{"key":"10.1016\/j.intimp.2023.109927_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105754","article-title":"Aducanumab for Alzheimer\u2019s disease: A regulatory perspective","volume":"171","author":"Nistic\u00f2","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.intimp.2023.109927_b0020","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.intimp.2023.109927_b0025","article-title":"Effect of reductions in amyloid levels on cognitive change in randomized trials: Instrumental variable meta-analysis","volume":"372","author":"Ackley","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2023.109927_b0030","first-page":"9343514","article-title":"Aducanumab therapy to treat Alzheimer's disease: A narrative review","volume":"2022","author":"Beshir","year":"2022","journal-title":"Int. J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.intimp.2023.109927_b0035","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.tips.2019.10.006","article-title":"Phosphodiesterase Type 4 inhibition in CNS diseases","volume":"40","author":"Blokland","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.109927_b0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-6606-5-14","article-title":"The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB","volume":"5","author":"Kandel","year":"2012","journal-title":"Mol. Brain"},{"key":"10.1016\/j.intimp.2023.109927_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135281","article-title":"Roflumilast: A potential drug for the treatment of cognitive impairment?","volume":"736","author":"Sugin","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.intimp.2023.109927_b0050","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.7150\/ijbs.26230","article-title":"Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke","volume":"14","author":"Wang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2023.109927_b0055","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/s41386-018-0178-6","article-title":"Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice","volume":"43","author":"Zhang","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.intimp.2023.109927_b0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuron.2015.03.011","article-title":"Neuronal activity and CaMKII regulate kinesin-mediated transport of synaptic AMPARs","volume":"86","author":"Hoerndli","year":"2015","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.intimp.2023.109927_b0065","doi-asserted-by":"crossref","first-page":"19737","DOI":"10.1038\/s41598-021-98743-w","article-title":"The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP\/AMPK\/SIRT1 pathway","volume":"11","author":"Dong","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109927_b0070","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109927_b0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-3-319-58811-7_4","article-title":"The PDE4 cAMP-specific phosphodiesterases: Targets for drugs with antidepressant and memory-enhancing action","volume":"17","author":"Bolger","year":"2017","journal-title":"Advances in neurobiology."},{"key":"10.1016\/j.intimp.2023.109927_b0080","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.biopha.2017.01.059","article-title":"Inhibitor of phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's","volume":"88","author":"Kumar","year":"2017","journal-title":"Biomedecine & pharmacotherapie"},{"issue":"10","key":"10.1016\/j.intimp.2023.109927_b0085","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ijnp\/pyaa048","article-title":"The phosphodiesterase-4 inhibitor roflumilast, a potential treatment for the comorbidity of memory loss and depression in Alzheimer's disease: A preclinical study in APP\/PS1 transgenic mice","volume":"23","author":"Wang","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109927_b0090","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12640-022-00482-x","article-title":"Roflumilast reduces pathological symptoms of sporadic alzheimer's disease in rats produced by intracerebroventricular streptozotocin by inhibiting NF-\u03baB\/BACE-1 mediated A\u03b2 production in the hippocampus and activating the cAMP\/BDNF signalling pathway","volume":"40","author":"Hasan","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.intimp.2023.109927_b0095","doi-asserted-by":"crossref","first-page":"40115","DOI":"10.1038\/srep40115","article-title":"Comparison of the pharmacological profiles of selective PDE4B and PDE4D inhibitors in the central nervous system","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109927_b0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuropharm.2017.12.019","article-title":"Acute administration of roflumilast enhances immediate recall of verbal word memory in healthy young adults","volume":"131","author":"Van Duinen","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2023.109927_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114170","article-title":"Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease","volume":"232","author":"Xi","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2023.109927_b0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1759720X10381432","article-title":"Apremilast: A novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases","volume":"2","author":"Schett","year":"2010","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2023.109927_b0115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/bjp.2008.297","article-title":"Can the anti-inflammatory potential of PDE4 inhibitors be realized: Guarded optimism or wishful thinking?","volume":"155","author":"Giembycz","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109927_b0120","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/acer.13616","article-title":"Apremilast alters behavioral responses to ethanol in mice: I reduced consumption and preference","volume":"42","author":"Blednov","year":"2018","journal-title":"Alcoholism, clinical and experimental research"},{"key":"10.1016\/j.intimp.2023.109927_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108220","article-title":"Apremilast regulates acute effects of ethanol and other GABAergic drugs via protein kinase A-dependent signaling","volume":"178","author":"Blednov","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.intimp.2023.109927_b0130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1476-5381.2009.00559.x","article-title":"Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis","volume":"159","author":"Schafer","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109927_b0135","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/906349","article-title":"The pharmacodynamic impact of apremilast, an oral phosphodiesterase 4 inhibitor, on circulating levels of inflammatory biomarkers in patients with psoriatic arthritis: substudy results from a phase III, randomized, placebo-controlled trial (PALACE 1)","volume":"2015","author":"Schafer","year":"2015","journal-title":"J. Immunol. Res."},{"issue":"9","key":"10.1016\/j.intimp.2023.109927_b0140","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3846","article-title":"Effectiveness of apremilast in real life in patients with psoriasis: A longitudinal study","volume":"101","author":"Malara","year":"2021","journal-title":"Acta Derm. Venereol."},{"issue":"33","key":"10.1016\/j.intimp.2023.109927_b0145","article-title":"Apremilast prevents IL 17 induced cellular senescence in ATDC5 chondrocytes mediated by SIRT1","volume":"12","author":"Wang","year":"2021","journal-title":"Int J Mol Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.109927_b0150","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3390\/ijms23041989","article-title":"Aging, cellular senescence, and Alzheimer's disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.109927_b0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1538\/expanim.52.401","article-title":"The rat model of type 2 diabetic mellitus and its glycometabolism characters","volume":"52","author":"Zhang","year":"2003","journal-title":"Exp. Anim."},{"key":"10.1016\/j.intimp.2023.109927_b0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.biopha.2018.10.056","article-title":"Polyphenol-rich Boswellia serrata gum prevents cognitive impairment and insulin resistance of diabetic rats through inhibition of GSK3beta activity, oxidative stress and pro-inflammatory cytokines","volume":"109","author":"Gomaa","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2023.109927_b0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/fcp.12585","article-title":"Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats","volume":"35","author":"Gomaa","year":"2021","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109927_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170971","article-title":"Appropriate insulin level in selecting fortified diet-fed, streptozotocin-treated rat model of type 2 diabetes for anti-diabetic studies","volume":"12","author":"Okoduwa","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2023.109927_b0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/ph14010061","article-title":"Memory enhancers for Alzheimer's dementia: Focus on cGMP","volume":"14","author":"Fedele","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"10.1016\/j.intimp.2023.109927_b0180","first-page":"e1821","article-title":"Sensitive assessment of hippocampal learning using temporally dissociated passive avoidance task","volume":"6","author":"Eagle","year":"2016","journal-title":"Bio Protoc."},{"key":"10.1016\/j.intimp.2023.109927_b0185","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fneur.2019.00586","article-title":"Novel object recognition in rats with NMDAR dysfunction in CA1 after stereotactic injection of Anti-NMDAR encephalitis cerebrospinal fluid","volume":"10","author":"Kersten","year":"2019","journal-title":"Front Neurol."},{"key":"10.1016\/j.intimp.2023.109927_b0190","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3389\/fphar.2020.00985","article-title":"The neuroprotective action of amidated-kyotorphin on amyloid \u03b2 peptide-induced Alzheimer\u2019s disease pathophysiology","volume":"11","author":"Belo","year":"2020","journal-title":"Front Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109927_b0195","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2023.109927_b0200","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s13340-015-0212-4","article-title":"Glucose area under the curve during oral glucose tolerance test as an index of glucose intolerance","volume":"7","author":"Sakaguchi","year":"2016","journal-title":"Diabetol. Int."},{"issue":"2","key":"10.1016\/j.intimp.2023.109927_b0205","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0003-2697(90)90208-Q","article-title":"Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples","volume":"190","author":"Baker","year":"1990","journal-title":"Anal. Biochem."},{"issue":"28","key":"10.1016\/j.intimp.2023.109927_b0210","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/j.jchromb.2009.06.016","article-title":"Determination of glutathione and glutathione disulfide in biological samples: An in-depth review","volume":"877","author":"Monostori","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/j.intimp.2023.109927_b0215","first-page":"215","article-title":"Assay using brain homogenate for measuring the antioxidant activity of biological fluids","volume":"47","author":"Stocks","year":"1974","journal-title":"Clin. Sci. Mol. Med."},{"key":"10.1016\/j.intimp.2023.109927_b0220","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0076-6879(90)86135-I","article-title":"Malondialdehyde determination as index of lipid peroxidation","volume":"186","author":"Draper","year":"1990","journal-title":"Methods Enzymol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109927_b0225","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00702-014-1319-7","article-title":"In vitro streptozotocin model for modeling Alzheimer-like changes: Effect on amyloid precursor protein secretases and glycogen synthase kinase-3","volume":"122","author":"Plaschke","year":"2015","journal-title":"J. Neural Trans. (Vienna, Austria: 1996)"},{"issue":"5","key":"10.1016\/j.intimp.2023.109927_b0230","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.brainresbull.2010.04.015","article-title":"Depressive-like-behavior and proinflamatory interleukine levels in the brain of rats submitted to pneumococcal meningitis","volume":"82","author":"Barichello","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2023.109927_b0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2015.04.014","article-title":"The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease","volume":"283","author":"Dursun","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109927_b0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/bc.bc_27_16","article-title":"Prospective clinical biomarkers of caspase-mediated apoptosis associated with neuronal and neurovascular damage following stroke and other severe brain injuries: Implications for chronic neurodegeneration","volume":"3","author":"Glushakova","year":"2017","journal-title":"Brain circulation."},{"issue":"1","key":"10.1016\/j.intimp.2023.109927_b0245","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-3806(97)00177-6","article-title":"Ontogenetic differences in the regional and cellular acetylcholinesterase and butyrylcholinesterase activity in the rat brain","volume":"105","author":"Lassiter","year":"1998","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.intimp.2023.109927_b0250","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s11033-016-4015-x","article-title":"Validation of reference genes for quantitative real-time PCR in valproic acid rat models of autism","volume":"43","author":"Zhou","year":"2016","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.intimp.2023.109927_b0255","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneumeth.2008.09.013","article-title":"NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: Application of laser microdissection technique","volume":"176","author":"Xi","year":"2009","journal-title":"J. Neurosci. Methods"},{"issue":"32","key":"10.1016\/j.intimp.2023.109927_b0260","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1523\/JNEUROSCI.3380-11.2012","article-title":"JNK1 inhibits GluR1 expression and GluR1-mediated calcium influx through phosphorylation and stabilization of Hes-1","volume":"2012","author":"Lin","year":"2012","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.intimp.2023.109927_b0265","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/bpa.12335","article-title":"Altered machinery of protein synthesis in Alzheimer's: From the nucleolus to the ribosome","volume":"26","author":"Hern\u00e1ndez-Ortega","year":"2016","journal-title":"Brain Pathol. (Zurich, Switzerland)."},{"issue":"1","key":"10.1016\/j.intimp.2023.109927_b0270","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3171\/JNS\/2008\/108\/01\/0124","article-title":"Normoxic ventilatory resuscitation following controlled cortical impact reduces peroxynitrite-mediated protein nitration in the hippocampus","volume":"108","author":"Ahn","year":"2008","journal-title":"Journal of neurosurgery."},{"key":"10.1016\/j.intimp.2023.109927_b0275","doi-asserted-by":"crossref","unstructured":"A. Sierksma, D. Van Den Hove, F. Pfau, M. Philippens, O. Bruno, E. Fedele, et al. Improvement of spatial memory function in APPswe\/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D. 77 (2014) 120\u2013130.","DOI":"10.1016\/j.neuropharm.2013.09.015"},{"key":"10.1016\/j.intimp.2023.109927_b0280","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnagi.2018.00204","article-title":"Inhibition of phosphodiesterase-4 reverses A\u03b2-induced memory impairment by regulation of HPA axis related cAMP signaling","volume":"10","author":"Xu","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2023.109927_b0285","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/ijms23031209","article-title":"Clinical Implication of Phosphodiesterase-4-Inhibition","volume":"23","author":"Schick","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"12","key":"10.1016\/j.intimp.2023.109927_b0290","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/ph13120484","article-title":"Apremilast microemulsion as topical therapy for local inflammation: Design, characterization and efficacy evaluation","volume":"13","author":"Sarango-Granda","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"8","key":"10.1016\/j.intimp.2023.109927_b0295","first-page":"835","article-title":"Mechanisms underlying the clinical effects of apremilast for psoriasis","volume":"17","author":"Pincelli","year":"2018","journal-title":"J. Drug Dermatol.: JDD."},{"issue":"1","key":"10.1016\/j.intimp.2023.109927_b0300","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41598-020-57542-5","article-title":"Large-scale analyses of disease biomarkers and apremilast pharmacodynamic effects","volume":"10","author":"Medvedeva","year":"2020","journal-title":"Scientific Reports"},{"issue":"11","key":"10.1016\/j.intimp.2023.109927_b0305","first-page":"2526","article-title":"Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis","volume":"18","author":"Danese","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol. Official Clin. Practice J. Am. Gastroenterol. Assoc."},{"issue":"5","key":"10.1016\/j.intimp.2023.109927_b0310","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","article-title":"Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model","volume":"22","author":"Zhang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2023.109927_b0315","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/DDDT.S269029","article-title":"Roflumilast attenuates doxorubicin-induced cardiotoxicity by targeting inflammation and cellular senescence in cardiomyocytes mediated by SIRT1","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2023.109927_b0320","doi-asserted-by":"crossref","first-page":"572","DOI":"10.18632\/aging.203835","article-title":"Combination of dasatinib and quercetin improves cognitive abilities in aged male Wistar rats, alleviates inflammation and changes hippocampal synaptic plasticity and histone H3 methylation profile","volume":"14","author":"Krzystyniak","year":"2022","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.intimp.2023.109927_b0325","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14283\/jpad.2021.62","article-title":"Senolytic therapy to modulate the progression of Alzheimer's disease (SToMP-AD): A pilot clinical trial","volume":"9","author":"Gonzales","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.intimp.2023.109927_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.864758","article-title":"Cerebral microvascular senescence and inflammation in diabetes","volume":"13","author":"Phoenix","year":"2022","journal-title":"Front Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109927_b0335","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1111\/1346-8138.16286","article-title":"Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients","volume":"49","author":"Ikumi","year":"2022","journal-title":"J. Dermatol."},{"issue":"10","key":"10.1016\/j.intimp.2023.109927_b0340","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00125-012-2632-z","article-title":"The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db\/db mice","volume":"55","author":"Vollert","year":"2012","journal-title":"Diabetologia."},{"key":"10.1016\/j.intimp.2023.109927_b0345","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/DMSO.S182953","article-title":"Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight\/obesity involve age-associated fat mass loss - results of an exploratory study","volume":"12","author":"Muo","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"21","key":"10.1016\/j.intimp.2023.109927_b0350","doi-asserted-by":"crossref","first-page":"8244","DOI":"10.3390\/ijms21218244","article-title":"Role of phosphodiesterase in the biology and pathology of diabetes","volume":"21","author":"Kilanowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.109927_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer's disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.109927_b0360","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/cells10020262","article-title":"Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration","volume":"10","author":"Rippin","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.intimp.2023.109927_b0365","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.654931","article-title":"The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain","volume":"13","author":"Gasiorowska","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2023.109927_b0370","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.biopha.2018.01.093","article-title":"Phosphodiesterase-4 inhibition confers a neuroprotective efficacy against early brain injury following experimental subarachnoid hemorrhage in rats by attenuating neuronal apoptosis through the SIRT1\/Akt pathway","volume":"99","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2023.109927_b0375","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/ijms23020616","article-title":"Neuroinflammation: A Potential Risk for Dementia","volume":"23","author":"Ahmad","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"2","key":"10.1016\/j.intimp.2023.109927_b0380","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0893-133X(00)00108-1","article-title":"Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism","volume":"23","author":"Zhang","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.intimp.2023.109927_b0385","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0167-4943(93)90009-7","article-title":"Effects of repeated administration of rolipram, a cAMP-specific phosphodiesterase inhibitor, on acetylcholinergic indices in the aged rat brain","volume":"16","author":"Asanuma","year":"1993","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"3","key":"10.1016\/j.intimp.2023.109927_b0390","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s12640-021-00340-2","article-title":"The protective effects of apremilast against oxygen-glucose deprivation\/reperfusion (OGD\/R)-induced inflammation and apoptosis in astroglia mediated by CREB\/BDNF","volume":"39","author":"Yin","year":"2021","journal-title":"Neurotox Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.109927_b0395","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11011-018-0374-4","article-title":"Roflumilast ameliorates cognitive impairment in APP\/PS1 mice via cAMP\/CREB\/BDNF signaling and anti-neuroinflammatory effects","volume":"34","author":"Feng","year":"2019","journal-title":"Metab. Brain Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:50:56Z","timestamp":1761587456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923002473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":79,"alternative-id":["S1567576923002473"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109927","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109927"}}